Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.

Autor: Luo W; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA. Wen_Luo@nymc.edu.; Department of Pathology, Immunology and Microbiology, New York Medical College, Valhalla, NY, 10595, USA. Wen_Luo@nymc.edu., Hoang H; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA., Miller KE; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University, Columbus, OH, USA., Zhu H; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA., Xu S; James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA., Mo X; Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, OH, USA., Garfinkle EAR; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University, Columbus, OH, USA., Costello H; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA., Wijeratne S; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA., Chemnitz W; Department of Medicine, New York Medical College, Valhalla, NY, USA., Gandhi R; University of Chicago, Chicago, IL, USA., Liao Y; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA., Ayello J; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA., Gardenswartz A; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA., Rosenblum JM; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA., Cassady KA; Center for Childhood Cancer Research, Nationwide Children's Hospital, Columbus, OH, USA., Mardis ER; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University, Columbus, OH, USA.; Department of Neurosurgery, The Ohio State University, Columbus, OH, USA., Lee DA; Department of Pediatrics, The Ohio State University, Columbus, OH, USA., Cripe TP; Department of Pediatrics, The Ohio State University, Columbus, OH, USA.; Center for Childhood Cancer Research, Nationwide Children's Hospital, Columbus, OH, USA., Cairo MS; Department of Pediatrics, New York Medical College, 15 Dana Road, Valhalla, NY, 10595, USA. Mitchell_Cairo@nymc.edu.; Department of Pathology, Immunology and Microbiology, New York Medical College, Valhalla, NY, 10595, USA. Mitchell_Cairo@nymc.edu.; Department of Medicine, New York Medical College, Valhalla, NY, USA. Mitchell_Cairo@nymc.edu.; Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA. Mitchell_Cairo@nymc.edu.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jul 11; Vol. 43 (1), pp. 193. Date of Electronic Publication: 2024 Jul 11.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

121 - A PHASE I TRIAL OF TARGETED IMMUNOTHERAPY WITH DARATUMUMAB FOLLOWING MYELOABLATIVE TOTAL BODY IRRADIATION (TBI)-BASED CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATON IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH HIGH-RISK T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC FACILITATED STUDY

Autor: Quigg, T., Flower, A., Teachey, D., Lim, M., Chu, Y., Harrison, L., Morris, E., Gardenswartz, A., Hochberg, J., Ozkaynak, M., Rosenblum, J., Milner, J., Pehlivan, K., Levendoglu-Tugal, O., Fabricatore, S., Wolownik, K., Ayello, J., Rigot, O., Klejmont, L., Campbell, M., Gonzalez, I., Otero, N., Budhram, A., Mintzer, E., Mahanti, H., Dufresne, J., Liu, D., Ahmed, T., Steinberg, A., Sweeney, R., McHale, P., Islam, H., Gerard, P., Moorthy, C., Voss, S., Miles, R., Audino, A., Mo, X., Stanek, J., Olshen, A., Hermiston, M., Seif, A., Cairo, M.

Publikováno v: In Leukemia Research October 2022 121 Supplement:S71-S73

Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.

Autor: Chu Y; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Milner J; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Lamb M; Department of Hematology/Oncology/Bone Marrow Transplant, Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA., Maryamchik E; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Perlman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Rigot O; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Ayello J; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Harrison L; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Shaw R; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Behbehani GK; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Mardis ER; Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA.; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Miller K; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Prakruthi Rao Venkata L; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Chang H; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Lee D; Department of Hematology/Oncology/Bone Marrow Transplant, Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA., Rosenthal E; Department of Pediatrics, New York Medical College, Valhalla, New York, USA., Kadauke S; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Bunin N; Perlman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Talano JA; Department of Pediatrics, Hematology/Oncology and BMT, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Johnson B; Department of Medicine, Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Wang Y; Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Perlman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Cairo MS; Department of Pediatrics, New York Medical College, Valhalla, New York, USA.; Department of Medicine, New York Medical College, Valhalla, New York, USA.; Department of Microbiology, Immunology, and Pathology, New York Medical College, Valhalla, New York, USA.; Department of Cell Biology and Anatomy, New York Medical College, Valhalla, New York, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Mar 28; Vol. 227 (6), pp. 788-799.

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease.

Autor: Chu Y; Department of Pediatrics, New York Medical College, Valhalla, NY, United States., Talano JA; Department of Pediatrics, Hematology/Oncology and BMT, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, United States., Baxter-Lowe LA; Department of Pathology, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA, United States., Verbsky JW; Department of Pediatrics, Hematology/Oncology and BMT, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, United States., Morris E; Department of Pediatrics, New York Medical College, Valhalla, NY, United States., Mahanti H; Department of Pediatrics, New York Medical College, Valhalla, NY, United States., Ayello J; Department of Pediatrics, New York Medical College, Valhalla, NY, United States.; Department of Pathology, New York Medical College, Valhalla, NY, United States., Keever-Taylor C; Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States., Johnson B; Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States., Weinberg RS; New York Blood Center, New York, NY, United States., Shi Q; Department of Epidemiology and Community Health, New York Medical College, Valhalla, NY, United States., Moore TB; Department of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States., Fabricatore S; Department of Pediatrics, New York Medical College, Valhalla, NY, United States., Grossman B; Department of Pathology and Immunology, Washington University, St Louis, MO, United States., van de Ven C; Department of Pediatrics, New York Medical College, Valhalla, NY, United States., Shenoy S; Department of Pediatrics and Transfusion Medicine, Washington University, St Louis, MO, United States., Cairo MS; Department of Pediatrics, New York Medical College, Valhalla, NY, United States.; Department of Pathology, New York Medical College, Valhalla, NY, United States.; Department of Medicine, New York Medical College, Valhalla, NY, United States.; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY, United States.; Department of Cell Biology, New York Medical College, Valhalla, NY, United States.; Department of Anatomy, New York Medical College, Valhalla, NY, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Dec 09; Vol. 13, pp. 1055497. Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2022).